Real-time estimation of the time-varying transmission advantage of Omicron in England using S-Gene Target Status as a Proxy.
ABBOTT, S; Sherratt, K; FUNK, S;
Menzies, NA; QUAIFE, M; Allwood, BW; Byrne, AL; Coussens, AK; Harries, AD; Marx, FM; Meghji, J; PEDRAZZOLI, D; Salomon, JA; SWEENEY, S; Van Kampen, SC; Wallis, RS; HOUBEN, RM G J; Cohen, T;
LANCET GLOBAL HEALTH, (2021).9 12
Kovacevic, A; EGGO, RM; BAGUELIN, M; Domenech de Cellès, M; Opatowski, L;
The Journal of Infectious Diseases, (2021).225 2
Palmer, J; SHERRATT, K; Martin-Nielsen, R; Bevan, J; GIBBS, H; Group, C; FUNK, S; ABBOTT, S;
Journal of Open Source Software, (2021).6 63
Supplementary material from "Interventions targeting non-symptomatic cases can be important to prevent local outbreaks: SARS-CoV-2 as a case study".
Lovell-Read, FA; FUNK, S; Obolski, U; Donnelly, CA; Thompson, RN;
, The Royal Society (2021).
MCCREESH, N; Karat, A; GOVENDER, I; BAISLEY, K; Diaconu, K; Yates, T; HOUBEN, RM G J; Kielmann, K; GRANT, A; WHITE, R;
PAVELKA, M; Van-Zandvoort, K; ABBOTT, S; SHERRATT, K; Majdan, M; CMMID COVID-19 working group,; Inštitút Zdravotných Analýz,; Jarčuška, P; Krajčí, M; FLASCHE, S; FUNK, S;
Science (New York, N.Y.), (2021).372 6542
Wimalasiri-Yapa, BM C R; Barrero, RA; Stassen, L; Hafner, LM; McGraw, EA; Pyke, AT; Jansen, CC; Suhrbier, A; YAKOB, L; Hu, W; Devine, GJ; Frentiu, FD;
Open Biology, (2021).11 1
Privor-Dumm, LA; Poland, GA; Barratt, J; Durrheim, DN; Deloria Knoll, M; Vasudevan, P; JIT, M; Bonvehí, PE; Bonanni, P; International Council on Adult Immunization,;
